HAVN Life Sciences Inc
OTC:HAVLF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
HAVN Life Sciences Inc
OTC:HAVLF
|
CA |
|
V
|
Valmet Corp
XMUN:2VO
|
FI |
|
B
|
Bilfinger Se
XMUN:GBF
|
DE |
|
A
|
Acciona SA
DUS:AJ3
|
ES |
|
I
|
Immuron Ltd
F:ANWA
|
AU |
|
Valmet Corp
OTC:VLMTY
|
FI |
|
Intelligent Monitoring Group Ltd
ASX:IMB
|
AU |
|
D
|
Del Monte Pacific Ltd
XPHS:DELM
|
VG |
|
A
|
Autohome Inc
F:8AHB
|
CN |
|
G
|
Givaudan SA
DUS:GIN
|
CH |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for HAVN Life Sciences Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What HAVN Life Sciences Does
HAVN Life Sciences, Inc. is a biotechnology company, which provides psychedelic therapies through technology-focused, data-driven, and medical-based solutions. The firm is focused on standardizing the extraction of psychoactive compounds, the development of natural health products, and developing mental health treatments to support brain health and enhance the capabilities of the mind. HAVN Labs is engaged in the development of its first psilocybin grow in Jamaica and will operate from its research facility in Vancouver.
- Headquarters
- Canada CA
- Employees
- 6
- IPO date
- Sep 8, 2020
